HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoyu Liu Selected Research

Japanese Encephalitis Vaccines

6/2022Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.
12/2021Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoyu Liu Research Topics

Disease

49Neoplasms (Cancer)
07/2022 - 10/2010
21Inflammation (Inflammations)
02/2022 - 01/2013
13Infections
12/2022 - 01/2013
12Wounds and Injuries (Trauma)
06/2022 - 02/2013
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2014
10Neoplasm Metastasis (Metastasis)
05/2022 - 11/2015
10Asthma (Bronchial Asthma)
01/2021 - 12/2012
8Hypoxia (Hypoxemia)
03/2022 - 07/2012
8Breast Neoplasms (Breast Cancer)
12/2021 - 01/2009
8Atherosclerosis
01/2021 - 10/2014
8Heart Failure
01/2021 - 01/2012
7Carcinogenesis
12/2021 - 02/2013
6Liver Neoplasms (Liver Cancer)
03/2022 - 01/2014
6Hypersensitivity (Allergy)
01/2021 - 01/2013
6Respiratory Hypersensitivity
01/2019 - 01/2013
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 03/2016
5Vascular Calcification
01/2021 - 10/2018
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 09/2012
5Colorectal Neoplasms (Colorectal Cancer)
04/2020 - 01/2018
4Pain (Aches)
10/2022 - 01/2021
4Disease Resistance
07/2022 - 06/2019
4Obesity
01/2022 - 04/2004
4Cysts
10/2021 - 11/2019
4Stomach Neoplasms (Stomach Cancer)
10/2021 - 12/2017
4Brain Injuries (Brain Injury)
10/2021 - 01/2014
4Chronic Renal Insufficiency
01/2021 - 01/2020
4Neuroinflammatory Diseases
01/2020 - 03/2016
4Myocardial Infarction
11/2019 - 05/2013
4Food Hypersensitivity (Food Allergy)
01/2017 - 01/2013
3Cognitive Dysfunction
10/2022 - 01/2020
3Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2018
3Lung Neoplasms (Lung Cancer)
03/2022 - 06/2019
3Adenocarcinoma
01/2022 - 03/2016
3Triple Negative Breast Neoplasms
01/2022 - 11/2017
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 07/2021
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2021 - 01/2020
3Fibrosis (Cirrhosis)
10/2021 - 02/2013
3Ischemic Stroke
10/2021 - 01/2020
3Nasopharyngeal Carcinoma
10/2021 - 02/2014
3Proteinuria
01/2021 - 01/2016
3Infertility (Sterility)
01/2021 - 01/2017
3Bacterial Infections (Bacterial Infection)
01/2021 - 05/2016
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 11/2018
3Hyperglycemia
11/2020 - 01/2016
3Hereditary Nephritis (Alport Syndrome)
01/2020 - 01/2016
3Neuralgia (Stump Neuralgia)
01/2020 - 09/2013
3Hypertrophy
01/2014 - 01/2012

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2004
14CytokinesIBA
01/2022 - 01/2013
13Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2017
13MicroRNAs (MicroRNA)IBA
07/2021 - 04/2012
10Biological ProductsIBA
05/2022 - 04/2012
9RNA (Ribonucleic Acid)IBA
10/2022 - 10/2017
9AllergensIBA
01/2022 - 01/2013
7Messenger RNA (mRNA)IBA
02/2022 - 02/2014
7Glucose (Dextrose)FDA LinkGeneric
11/2021 - 07/2010
7Immunoglobulin E (IgE)IBA
01/2017 - 01/2013
6DNA (Deoxyribonucleic Acid)IBA
10/2022 - 02/2014
5CollagenIBA
07/2022 - 01/2016
5VaccinesIBA
06/2022 - 10/2012
5AntigensIBA
03/2022 - 03/2013
5InterferonsIBA
02/2022 - 01/2015
5Protein Kinases (Protein Kinase)IBA
01/2022 - 04/2014
5Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2016
5Immunoglobulin G (IgG)IBA
09/2017 - 01/2013
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 09/2015
4Interleukin-6 (Interleukin 6)IBA
02/2022 - 09/2015
4Polysaccharides (Glycans)IBA
01/2022 - 04/2014
4Retinaldehyde (Retinal)IBA
01/2022 - 04/2013
4Peptides (Polypeptides)IBA
10/2021 - 10/2012
4Pharmaceutical PreparationsIBA
11/2020 - 01/2012
4CalciumIBA
01/2020 - 11/2013
4ElementsIBA
05/2018 - 04/2013
4EnzymesIBA
03/2018 - 01/2015
3Small Interfering RNA (siRNA)IBA
07/2022 - 10/2014
3HydrogelsIBA
06/2022 - 11/2017
3alpha-SynucleinIBA
06/2022 - 01/2018
3GlypicansIBA
03/2022 - 10/2019
3Interleukin-4 (Interleukin 4)IBA
02/2022 - 01/2015
3AntibodiesIBA
01/2022 - 01/2013
3LipidsIBA
01/2022 - 01/2009
3Oxygen (Dioxygen)IBA
11/2021 - 07/2010
3Vasopressins (Vasopressin)IBA
10/2021 - 01/2020
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 08/2017
3Long Noncoding RNAIBA
01/2021 - 01/2020
3LipopolysaccharidesIBA
11/2020 - 12/2012
3Plant Growth Regulators (Plant Hormones)IBA
01/2020 - 01/2017
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 09/2013
3Phosphotransferases (Kinase)IBA
01/2019 - 01/2014
3Apolipoproteins E (ApoE)IBA
01/2019 - 10/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 01/2017
3SmokeIBA
01/2017 - 01/2013
3OvalbuminIBA
01/2017 - 12/2014
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2022 - 01/2021

Therapy/Procedure

28Therapeutics
03/2022 - 07/2013
8Drug Therapy (Chemotherapy)
01/2020 - 12/2013
7Immunotherapy
05/2022 - 01/2013
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2013
3Transplantation
01/2020 - 03/2011
3Oral Administration
01/2017 - 06/2009